Literature DB >> 10868895

Therapy of Helicobacter pylori: current status and issues.

D Y Graham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10868895     DOI： 10.1016/s0016-5085(00)70003-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  19 in total

1.  The detection of inherent homologous recombination between repeat sequences in H. pylori 26695 by the PCR-based method.

Authors:  Yajuan Fu; Reyna Cristina Zepeda-Gurrola; Germán Rubén Aguilar-Gutiérrez; Edgar E Lara-Ramírez; Erick J De Luna-Santillana; Isabel Cristina Rodríguez-Luna; Alejandro Sánchez-Varela; Ricardo Carreño-López; Víctor Ricardo Moreno-Medina; Mario A Rodríguez-Pérez; Yolanda López-Vidal; Xianwu Guo
Journal:  Curr Microbiol       Date:  2013-10-06       Impact factor: 2.188

2.  Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.

Authors:  Jed W Fahey; Xavier Haristoy; Patrick M Dolan; Thomas W Kensler; Isabelle Scholtus; Katherine K Stephenson; Paul Talalay; Alain Lozniewski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.

Authors:  Jeng Yih Wu; Jae J Kim; Rita Reddy; W M Wang; David Y Graham; Dong H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

5.  Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.

Authors:  Hedvig E Jakobsson; Cecilia Jernberg; Anders F Andersson; Maria Sjölund-Karlsson; Janet K Jansson; Lars Engstrand
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

6.  Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance.

Authors:  M Dehesa; J Larisch; M Dibildox; M Di Silvio; L H Lopez; E Ramirez-Barba; J Torres
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

Review 7.  New concepts of resistance in the treatment of Helicobacter pylori infections.

Authors:  David Y Graham; Akiko Shiotani
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-04-29

8.  High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.

Authors:  Dong H Kwon; M P Dore; J J Kim; M Kato; M Lee; J Y Wu; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

9.  Aspirin increases susceptibility of Helicobacter pylori to metronidazole by augmenting endocellular concentrations of antimicrobials.

Authors:  Xiao-Ping Zhang; Wei-Hong Wang; Yu Tian; Wen Gao; Jiang Li
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

10.  High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial.

Authors:  Petra Bago; Aleksandar Vcev; Monika Tomic; Marjan Rozankovic; Marinko Marusić; Josip Bago
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.